Episode 38 - Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal - Part 5: Secondary HLH/MAS & Updates from ASH
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Episode 38 - Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal - Part 5: Secondary HLH/MAS & Updates from ASH
-
ナレーター：
-
著者：
このコンテンツについて
Conversations in IFN-y explores the latest advancements in understanding and managing secondary hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS), with updates from ASH 2024. Featuring discussions by leading experts, the educational activity covers breakthroughs in diagnostic technologies. Topics covered include AI-based histology models and PET/CT imaging, therapeutic innovations such as emapalumab and reduced-intensity conditioning for HSCT. The implications of these findings for improving outcomes in diverse patient populations, including malignancy- and pregnancy-associated HLH will also be discussed.
Launch Date: January 9, 2025
Release Date: January 9, 2025
Expiration Date: December 31, 2025
FACULTY
Pui Lee, MD
Assistant Professor of Pediatrics
Boston Childrens Hospital
Ashish Kumar, MD, PhD
Professor of Pediatrics
Cincinnati Children's Hospital Medical Center
Alexei Grom, MD
Professor of Pediatrics
Research Director
Division of Rheumatology
Cincinnati Children’s Hospital Medical Center
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.